RxDoctor Payments Data

Mark Wright, NP

Nurse Practitioner · Houma, LANPI 1770772170

Payments from drug & device makers

$1,159in general payments, 2019–2025

Across 65 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kestra Medical Technology Services, Inc.$186
  • Novartis$150
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$99
  • Amgen$79
  • Abiomed$78
  • Boehringer Ingelheim$57
  • plus $511 from 14 others

What the payments were for

  • Food & beverage$1,159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,159 in reported general payments places this provider in the 70th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Medicare billing

Part B allowed, 2024
$2,478
Medicare patients
27
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$19,813
BrilintaTicagrelor21$9,035
Rosuvastatin Calcium46$867
Olmesartan Medoxomil14$679
Atorvastatin Calcium85$642
Valsartan37$589
Metoprolol Succinate51$559
Isosorbide Mononitrate ErIsosorbide Mononitrate47$449
Pantoprazole Sodium22$324
ClopidogrelClopidogrel Bisulfate37$276
Doxazosin Mesylate21$231
Carvedilol23$219
Amlodipine Besylate50$176
Lisinopril27$173
Losartan Potassium33$165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$50$19,81327 claims
AstraZenecaBrilinta$39$9,03521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 969 nurse practitioner providers in Louisiana.

Other nurse practitioner in Houma

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →